Specifications table {#s0005}
====================

TableSubject area*Bioсhemistry, Chemistry, Nanobiotechnology*More specific subject area*Synthesis of phosphorylated nucleosides and their conjugation to SiO*~*2*~*nanoparticles*Type of data*Experimental synthesis protocols, Tables, Figures, Text file*How data was acquired*NMR, IR, mass spectrometry, analytical HPLC, MTT assay*Data format*Raw, Analyzed*Experimental factors*γ-Alkynyl 2*′*,3*′*-dideoxyuridine triphosphate was synthesized and characterized. A conjugate of the triphosphate with SiO*~*2*~*nanoparticle was then obtained by click-chemistry. Chemical stability of the conjugate at different pH values was studied and its cytotoxicity for MCF7 cells analyzed.*Experimental features*Experimental details of the synthesis of 2*′*,3*′*-dideoxyuridine triphosphate conjugated to SiO*~*2*~*nanoparticles; data on chemical stability and antiproliferative activity of the conjugate.*Data source location*Novosibirsk, Russia*Data accessibility*The data are available with this article*Related research article*This data set is submitted as a companion paper to the research article:* Svetlana V. Vasilyeva, Inga R. Grin, Boris P. Chelobanov, Dmitry A. Stetsenko. 2′,3′-Dideoxyuridine triphosphate conjugated to SiO~2~ nanoparticles: synthesis and evaluation of antiproliferative activity. *Bioorg Med Chem Lett.* 2018; 28:1248, DOI: [10.1016/j.bmcl.2018.02.007](http://10.1016/j.bmcl.2018.02.007){#ir0005}.

Value of the data {#s0010}
=================

•The paper relates to the research area of nanoparticle-based biomaterials for biomedical and bioengineering applications.•This data set presents a protocol for synthesis and characterization of a new bionanoconjugate, which could be used by researchers in the same area.•The data include a preliminary assessment of antiproliferative properties of a novel conjugate of 2′,3′-dideoxyuridine triphosphate with SiO~2~ nanoparticles.

1. Data {#s0015}
=======

Data set includes experimental conditions for the synthesis of 2′,3′-dideoxyuridine-5′-{*N*-\[4-(prop-2-yn-1-yloxy)butyl\]-γ-amino}-triphosphate and its characterization by ^1^H, ^13^C, and ^31^P NMR, IR and ESI-MS ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}), and protocol for its click-chemistry conjugation to azido-modified SiO~2~ nanoparticles [@bib1], [@bib2]. Experimental data on chemical stability of the conjugate at different pH values are presented ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}). Cytotoxicity of the conjugate for MCF7 cell line has been assessed ([Table 3](#t0015){ref-type="table"}).Fig. 1^1^H NMR spectrum of L\~pppddU.Fig. 1Fig. 2^31^P NMR spectrum of L\~pppddU.Fig. 2Fig. 3^13^C NMR spectrum of L\~pppddU.Fig. 3Fig. 4ESI-MS of L\~pppddU. Calc. for \[M+H-Na\]^+^ 605.29 *m*/*z*, found 605.19.Fig. 4Fig. 5IR spectrum of L\~pppddU.Fig. 5Table 1Preparation of sample and control solutions.Table 1No. sampleCompoundConcentration, mMNucleotide content *ν*, µM/mgpH 7.3 (PBS)pH 6.5 (P)pH 1.5--2 (HCl)1ddU37.728.261.2MW 212.212pppddU28.815.434.6MW 520.273L\~pppddU31.144.920.0MW 579.095SiO~2~\~L\*\~pppddU88,880.400Table 2Stability of SiO~2~\~L\*\~pppddU conjugate and controls at different pH values.Table 2*N* sampleSampleLoss of nucleotide content in the sample[a](#tbl2fna){ref-type="table-fn"} after 48 h, %Nucleotide content, *ν* µM/mgpH 7.3 (PBS)pH 6.5 (P)pH 1.5--2 (HCl)1ddU000--2pppddU207--3L\~pppddU91451--5SiO~2~\~L\*\~pppddU364060.400[^1]Table 3IC~50~ values for MCF7 human breast adenocarcinoma cell line (means ± standard deviations).Table 3CompoundsIC~50~, (MTT),SiO~2~\~L\*\~pppddU183 ± 57 μg/mL or 22 ± 0.7 μMSiO~2~\~L\*no inhibitionddUno inhibitionpppddUno inhibitionL\~pppddUno inhibition

2. Experimental design, materials, and methods {#s0020}
==============================================

2.1. Materials and methods {#s0025}
--------------------------

Reagents and solvents were purchased from Sigma-Aldrich or Acros Organics, and used without purification. Aminoalkylated SiO~2~ nanoparticles were from SkySpring Nanomaterials (USA). Mass spectra were obtained on an Agilent 6410 Triple Quadrupole LC-MS device (USA).^1^H, ^13^C and ^31^P NMR spectra were recorded using Bruker AV-400, AV-300 or DRX-500 NMR spectrometers. UV absorption spectra were obtained on a Shimadzu UV-1800 spectrophotometer (Japan). Analytical HPLC was carried out on an Agilent 1200 Series LC system, using Zorbax^®^ 5 µm Eclipse-XDB-C18 80 Å column 150 × 4.6 mm by Agilent (USA).

2.2. Synthesis of 2′,3′-dideoxyuridine-5′-{*N*-\[4-(prop-2-yn-1-yloxy)butyl\]-γ-amino}-triphosphate (L\~pppddU) {#s0030}
---------------------------------------------------------------------------------------------------------------

2′,3′-Dideoxyuridine-5-triphosphate ammonium salt (pppddU) was synthesized according to [@bib3]. NMR data were in good agreement with the literature [@bib4]. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) (368 mg, 1.92 mmol, 5 equiv.) was dissolved in deionized water (4 mL), pppddU (200 mg, 0.384 mmol, 1.0 eq) was added and the pH was adjusted to 7.5 with aq NaOH (0.1 M, 0.6 mL). After stirring at ambient temperature for 7 min, 3-aminobutyl propargyl ether (220 µg, 0.844 mmol, 2.2 eq) was added. After complete consumption of the starting material according to RP-HPLC, the mixture was precipitated with 6% LiClO~4~ in acetone. Crude product was purified by anion exchange chromatography on DEAE Sephadex A-25 column eluted with a linear gradient from 20% EtOH to 1 M NH~4~HCO~3~ in 20% EtOH. Fractions were collected and evaporated to dryness, the residue was co-evaporated several times with 96% EtOH and the product was precipitated with 6% NaClO~4~ in acetone to yield 100 mg (45%) of the γ-alkynyl triphosphate, L\~pppddU. ^1^H NMR (500 MHz, D~2~O): *δ* (ppm) 7.9 (*d*, 1H, H(6)-(U), *J* = 7.7 Hz); 5.98--5.94 (*m*, 2H, H(5)-(U), H1′); 4.25--4.17 (*m*, 2H, H4′, H5′); 4.06--3.96 (*m*, 3H, H5′, OC*H*~2~C≡CH); 3.44 (*t*, 2H, OC*H*~2~(CH~2~)~3~NH, *J* = 6.5 Hz); 2.77--2.70 (*m*, 3H, O(CH~2~)~3~C*H*~2~NH, C*H*≡C); 2.34--2.27 (*m*, 1H, H2′); 1.97--1.93 (*m*, 3H, H3′, 2′); 1.84--1.83 (*m*, 1H, H3′); 1.49--1.32 (*m*, 4H, OCH~2~(C*H*~2~)~2~CH~2~NH). ^13^C NMR (75 MHz, D~2~O): *δ* (ppm) = 164.6 (4-C), 151.6 (2-C), 145.7 (6-C), 103.2 (5-C), 89.8.19 (1′-C), 82.9 (4′-C), 77.9 (12-C), 72.4 (10-C), 68.7 (11-C), 59.7 (5′-C), 57.1 (7-C), 43.6 (2′-C), 33.6 (3'-C), 29.6 (13-C), 26.7 (8-C), 26.6 (9-C). ^31^P NMR (121 MHz, D~2~O): *δ* (ppm) = − 0.3 (*d*, *J* = 20.69 Hz, *γ*-P), −10.74 (*d*, *J* = 18.69 Hz, *α*-P), − 22.10 (*t*, *J* = 20.03 Hz, *β*-P). UV spectrum (0.2 M NaOH): λ~max~ 260 nm, ε 1883. IR (cm^−1^): 3360, 3276, 3100, 2973, 2877, 2493, 1660, 1524, 1430, 1385, 1223, 1100, 995, 906, 810, 767. ESI-MS: \[M+H-Na\]^+^calcd for C16H24N3O13P3Na2=605.29, found 605.19.

2.3. Synthesis of SiO~2~\~L\*\~pppddU and control SiO~2~\~L^\*^conjugates by CuAAC reaction ([Fig. 6](#f0030){ref-type="fig"}) {#s0035}
------------------------------------------------------------------------------------------------------------------------------

Azido-modified SiO~2~ nanoparticles [@bib2] (40 mg, 17.2 µmol) were sonicated in 200 µL of H~2~O. A solution of L\~pppddU (100 mM in H~2~O, 1.386 mL, 139 µmoL, 8 equiv.) was added to the suspension followed by copper(II) sulfate (172 µL of 0.5 M solution in water), 1 M trietylammonium acetate (TEAAc) buffer, pH 7 (172 µL) and sodium ascorbate (86 µL of freshly prepared 1 M solution in water). The reaction mixture was purged with argon for 2 min and stirred at ambient temperature for 12 h. Conjugate was separated by centrifugation, supernatant was discarded. Precipitate was washed successively with 0.1 M NaCl, 10% Na~2~EDTA, water, diethyl ether followed by air drying. Yield: 38.5 mg. The control unloaded SiO2\~L\*\~conjugate was obtained as described above, but without addition of triphosphate. Yield: 9 mg. IR: N~3~ group band was absent. The nucleotide content of the conjugate was measured by UV absorbance after dissolving in 0.2 M NaOH. UV spectrum of L\~pppddU (0.2 M NaOH): λ~max~ 260 nm, ε 1883. Nucleotide content was calculated as UV absorbance of SiO~2~\~L\*\~pppddU conjugate minus UV absorbance of SiO~2~\~L\* conjugate: 0.4 µmol/mg ([Fig. 6](#f0030){ref-type="fig"}).Fig. 6Structure of the conjugate of 2′,3′-dideoxyuridine triphosphate with SiO~2~ nanoparticles (SiO~2~\~L\*\~pppddU) and control unloaded conjugate (SiO~2~\~L\*).Fig. 6

2.4. Hydrolysis of SiO~2~\~L\*\~pppddU conjugate at different pH {#s0040}
----------------------------------------------------------------

The conjugate (0.400 µM/mg nucleotide) was dispersed in three buffers with pH values corresponding to the pH in the blood (pH 7.3), the mouth (pH 6.5) and the stomach (pH 1.5--2.0) (2 mg in 100 µL of each buffer). Parent nucleoside (ddU), its 5'-triphosphate (pppddU) and alkynyl triphosphate (L\~pppddU) solutions in the same buffers were prepared ([Table 1](#t0005){ref-type="table"}). The solutions were incubated at 37 °C in a thermomixer. Initial aliquot (15 μL) was taken and analyzed by analytical HPLC at the wavelength 260 nm. Appropriate aliquots of buffers (15 μL) after centrifugation were analysed after 1, 4, 24 and 48 h. Percentage loss of the nucleotide content in the sample of SiO~2\~~L\*\~pppddU was evaluated at the end of the experiment. The remaining buffers were discarded after centrifugation; conjugate was washed successively with water followed by dissolution in 0.2 M NaOH and UV measurement of the remaining nucleotide content.

2.5. Cytotoxicity assay for human breast adenocarcinoma MCF7 cells {#s0045}
------------------------------------------------------------------

Cells were grown as adherent monolayer cultures in T25 cm^2^ culture flasks in complete Dulbecco׳s Modified Eagle׳s Medium (DMEM) supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 2 mM [L]{.smallcaps}-glutamine and 1% penicillin-streptomycin-amphotericin B. Cultures were grown at 37 °C under a humidified atmosphere of 5% CO~2~ at 37 °C. Cytotoxicity was determined by the colorimetric MTT assay [@bib5]. Cells were harvested from culture flasks by trypsin treatment and seeded in complete medium (100 μL/well) into 96-well plates at 1.5 × 104 cells per well. The cells were allowed to settle and resume proliferation for 24 h. Stock solutions of test compounds were prepared in DMEM, diluted by complete medium and immediately added to the plates (100 μL/well). Control groups with untreated cells were grown under the same condition in complete medium. After 72 h the medium was removed and replaced with 100 μL/well of 10% MTT solution in complete medium, and the cells were incubated for 3 h at 37 °C. The supernatant was removed, 100 μL of isopropanol was added, and the plates were gently shaken to solubilize the formazan crystals formed. Absorption was measured with a microplate reader (Multiscan EX, Thermo Fisher Scientific, Waltham, MA) at 570 nm and a reference wavelength of 620 nm. The cytotoxicity was expressed as cell growth inhibition (GI) at each group of the cells [@bib6], [@bib7]. All samples were analyzed using at least three independent experiments with triplicates for each concentration. The results are shown in [Table 3](#t0015){ref-type="table"}.
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=============================================

Supplementary material.

The work was supported by Russian Science Foundation Grant no. 17-44-07003.

Transparency data associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.09.127>.

[^1]: Loss of nucleotide content in the samples (1--3) due to decomposition of the controls.
